Semaglutide in Canada: GLP-1 Guide, Pricing & Providers | Semaglutide Canada
GENERIC SEMAGLUTIDE IS NOW IN CANADIAN PHARMACIES COMPARE PRICES →
Updated May 2026

Semaglutide in Canada

Real Canadian pricing, plain-language clinical research, and honest reviews of the providers prescribing Ozempic, Wegovy, and the newly launched generic semaglutide.

Canadian pricing, all 10 provinces
Clinical pages reviewed by a pharmacist
No manufacturer affiliation
Regulatory status

Health Canada approved. Apotex's generic semaglutide is in Canadian pharmacies; Dr. Reddy's has been off the market since an August 2026 recall.

Couple cooking together in a kitchen — Canadian semaglutide and GLP-1 medication guide
Generic semaglutide
In Canadian pharmacies since May 2026, from Apotex. Dr. Reddy's is off the market after an August 2026 recall.
Coverage tracked
All 10 provinces, public formularies and private plans.
Clinical review
Side effects, dosing and interactions reviewed by a Canadian pharmacist.
Independence
Not affiliated with any pharmaceutical manufacturer.

What You Need to Know in 2026

Semaglutide is the active ingredient in both Ozempic (approved for type 2 diabetes) and Wegovy (approved for weight management). It works by mimicking the GLP-1 hormone, which slows gastric emptying, reduces appetite, and helps regulate blood sugar. In the landmark STEP 1 trial, participants lost an average of 14.9% of their body weight over 68 weeks.

The biggest shift this year is that generic semaglutide is now available in Canada. After Novo Nordisk's data exclusivity expired on January 4, 2026, Health Canada authorized Dr. Reddy's on April 28, 2026 and Apotex on May 1, 2026. Both reached Canadian pharmacies in May 2026, but Dr. Reddy's has been off the market since an August 2026 recall, so today it is Apotex's Apo-Semaglutide on shelves, at about $88–$120 CAD per month, with Costco Pharmacy the lowest at roughly $88–$99. More applications from Sandoz, Teva Canada and others are under Health Canada review, which should push prices lower still as they launch through 2026.

Brand-name Ozempic still lists at $250–$310 per month and Wegovy at $376–$493 without insurance, though Novo Nordisk now offers an Ozempic savings card that brings brand Ozempic in line with the generic price for patients without coverage. Provincial plans mostly cover semaglutide for diabetes only (Special Authority required), while private insurance often covers it. Telehealth platforms have made getting a prescription faster than the clinic route, and several now dispense the generic at $149 a month. Our 2026 top pick in Ontario, BC, Alberta and Saskatchewan is BirchRx, which charges nothing for the assessment and nothing at all unless a physician approves you. MyRocky is cheaper across a full year and covers all 10 provinces, and Felix Health and Maple round out the list.

Who Writes This

Written by medical researchers. Reviewed by a Canadian pharmacist.

Every article is researched and written by our independent editorial team, then fact-checked against Health Canada filings, peer-reviewed studies, and Canadian provincial formularies, with articles reviewed by a Canadian-licensed pharmacist.

Canadian telehealth providers

Where Canadians get semaglutide online

Platforms where a Canadian patient can consult a physician and have semaglutide prescribed online. Prices are medication cost, not consultation fees.

ProviderBrand Ozempic / moGeneric / moCoverageConsult & fees
BirchRx Top pick
Not offered
$149 first mo
then $199
ON, BC, AB, SK only
Free assessment; pay only if approved
MyRocky Best 12-month value
From $200
$149
+ $60 program fee
All 10 provinces (incl. QC)
$99 consult, labs incl.; $60/mo program fee
$149
$149
per pen
All provinces (excl. QC)
$99 setup + $40 / quarter
Via pharmacy
Via pharmacy
9 provinces + Yukon
$49–$79 per visit or membership; labs separate
From $149
From $149
ON, BC, AB (expanding)
Included in program

BirchRx prescribes in Ontario, British Columbia, Alberta and Saskatchewan only, and is the cheapest way to start at $149 for month one against $248 elsewhere. MyRocky remains the pick in the other six provinces and for brand-name GLP-1s. Maple prescribes but does not dispense, so its medication cost is whatever your pharmacy charges. Provider names link to our full review.

Price alerts

Track every new generic semaglutide launch in Canada

Generic semaglutide is now available from Apotex, and Dr. Reddy's is off the market after an August 2026 recall. We'll email you as each new manufacturer (Sandoz, Teva and others) ships, pharmacy pricing drops, and provincial coverage changes.

Subscribing joins our Canadian GLP-1 newsletter. Unsubscribe from any email. Privacy and email policy.

Frequently Asked Questions

Yes. Health Canada approved Wegovy (semaglutide 2.4 mg) for chronic weight management in adults with a BMI of 30+, or 27+ with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or dyslipidemia. Ozempic is approved for type 2 diabetes but is frequently prescribed off-label for weight loss.
Yes. Semaglutide is prescription-only in Canada. You need a licensed physician or nurse practitioner to evaluate your medical history and write a prescription. This can be done through your family doctor, a walk-in clinic, or an accredited telehealth platform like Felix Health or Maple.
Brand-name Ozempic costs roughly $250–$310 CAD per month without insurance. Wegovy runs $376–$493 CAD per month. Generic semaglutide injection launched in Canadian pharmacies in May 2026. Apotex's Apo-Semaglutide is on shelves at roughly $88–$120 CAD per month; Dr. Reddy's has been off the market since an August 2026 recall. Prices are expected to drop further as Sandoz, Teva Canada and other applicants are approved.
Coverage varies by province. Most provincial formularies (OHIP, BC PharmaCare, Alberta Blue Cross) list Ozempic for type 2 diabetes with Special Authority approval, but coverage for weight management alone is limited. Private group insurance plans through employers often provide broader coverage. British Columbia recently added limited semaglutide coverage for weight management under specific criteria.
Yes — generic semaglutide injection launched in Canadian pharmacies in May 2026. Health Canada authorized Dr. Reddy's Laboratories on April 28, 2026 and Apotex on May 1, 2026, and Apotex's product is in pharmacies nationwide, while Dr. Reddy's has been off the market since an August 2026 recall. Additional applications from Sandoz, Teva Canada and other manufacturers remain under Health Canada review, which is expected to push prices down further as more competitors enter the market through the rest of 2026.
The most common side effects are gastrointestinal: nausea, diarrhea, vomiting, and constipation. These are typically mild to moderate and tend to decrease over the first 8–12 weeks as the dosage is gradually titrated upward. Serious but rare side effects include pancreatitis and gallbladder problems. Your prescribing physician will review your full risk profile before starting treatment.